Gene · 220
Papers1,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| GAD1 contributes to the progression and drug resistance in castration resistant prostate cancer. | Cancer Cell Int | 2023 | 37904122 | PubTator, text mining | PubMed |
| Genetic and epigenetic factors of arterial hypertension: a bibliometric- and in-silico-based analyses. | Front Mol Biosci | 2023 | 37900914 | PubTator, text mining | PubMed |
| Cancer Stem Cells and Androgen Receptor Signaling: Partners in Disease Progression. | Int J Mol Sci | 2023 | 37894767 | PubTator, text mining | PubMed |
| Stable Isotope-Assisted Untargeted Metabolomics Identifies ALDH1A1-Driven Erythronate Accumulation in Lung Cancer Cells. | Biomedicines | 2023 | 37893215 | PubTator, text mining | PubMed |
| Gene Expression Analyses in Models of Rosiglitazone-Induced Physiological and Pathological Mineralization Identify Novel Targets to Improve Bone and Vascular Health. | Cells | 2023 | 37887306 | PubTator, text mining | PubMed |
| White Adipose Tissue Heterogeneity in the Single-Cell Era: From Mice and Humans to Cattle. | Biology (Basel) | 2023 | 37886999 | PubTator, text mining | PubMed |
| Genetic vulnerability to Crohn's disease reveals a spatially resolved epithelial restitution program. | Sci Transl Med | 2023 | 37878672 | PubTator, text mining | PubMed |
| Modification of lysine-260 2-hydroxyisobutyrylation destabilizes ALDH1A1 expression to regulate bladder cancer progression. | iScience | 2023 | 37867947 | PubTator, text mining | PubMed |
| Transcriptome analysis reveals molecular signature and cell-type difference of Homo sapiens endothelial-to-mesenchymal transition. | G3 (Bethesda) | 2023 | 37857450 | PubTator, text mining | PubMed |
| Retinoic Acid Signaling in Fatty Liver Disease. | Liver Res | 2023 | 37854944 | PubTator, text mining | PubMed |
| Editorial: New insights in cellular and molecular biology of cancer stem cells. | Front Genet | 2023 | 37849502 | PubTator, text mining | PubMed |
| Editorial: Ferroptosis in malignant brain tumors. | Front Oncol | 2023 | 37841440 | PubTator, text mining | PubMed |
| Meta-analysis of lean and obese RNA-seq datasets to identify genes targeting obesity. | Bioinformation | 2023 | 37808366 | PubTator, text mining | PubMed |
| Inhibiting BRAF/EGFR/MEK suppresses cancer stemness and drug resistance of primary colorectal cancer cells. | Oncotarget | 2023 | 37791907 | PubTator, text mining | PubMed |
| Human umbilical cord mesenchymal stem cells in diabetes mellitus and its complications: applications and research advances. | Int J Med Sci | 2023 | 37790847 | PubTator, text mining | PubMed |
| Decoding the IL-33/ST2 Axis: Its Impact on the Immune Landscape of Breast Cancer. | Int J Mol Sci | 2023 | 37762328 | PubTator, text mining | PubMed |
| Endothelial Notch1 signaling in white adipose tissue promotes cancer cachexia. | Nat Cancer | 2023 | 37749321 | PubTator, text mining | PubMed |
| Characterization and therapeutic perspectives of differentiation-inducing therapy in malignant tumors. | Front Genet | 2023 | 37745860 | PubTator, text mining | PubMed |
| Permanent Neonatal diabetes-causing Insulin mutations have dominant negative effects on beta cell identity. | bioRxiv | 2023 | 37745320 | PubTator, text mining | PubMed |
| Identification of MIR600HG/hsa-miR-342-3p/ANLN network as a potential prognosis biomarker associated with lmmune infiltrates in pancreatic cancer. | Sci Rep | 2023 | 37741887 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/220/papers?page=9